Download PDF

Other users also viewed these articles

Treatment adherence in patients with multiple sclerosis: risk factors L.A. Rodríguez de Antonio; R. Fernández de Córdoba-García; N. Herrero-Muñoz; A. Ontañón-Nasarre; I. García-Castañón;
Neurologia. 2025;40:353-60
A comparative study of melatonin and immunomodulatory therapy with interferon beta and glatiramer acetate in a mouse model of multiple sclerosis E.J. Ramos González; L.J. Ramirez Jirano; D.Z. García Martínez; G.G. Ortiz; L.F. Jave Suárez; C.A. Leal Cortes; O.K. Bitzer Quintero;
Neurologia. 2021;36:262-70
Impact of fatigue on quality of life in adults with multiple sclerosis R. Piñar-Morales; P.A. Guirado-Ruiz; F.J. Barrero Hernández;
Neurologia. 2025;40:864-74